Literature DB >> 24380046

(68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes.

Renata Madru1, Thuy A Tran2, Johan Axelsson3, Christian Ingvar4, Adnan Bibic1, Freddy Ståhlberg5, Linda Knutsson1, Sven-Erik Strand2.   

Abstract

The aim of this study was to develop (68)Ga-SPIONs for use as a single contrast agent for dynamic, quantitative and high resolution PET/MR imaging of Sentinel Lymph Node (SLN). In addition (68)Ga enables Cherenkov light emission which can be used for optical guidance during resection of SLN. SPIONs were labeled with (68)Ga in ammonium acetate buffer, pH 5.5. The labeling yield and stability in human serum were determined using instant thin layer chromatography. An amount of 0.07-0.1 mL (~5-10 MBq, 0.13 mg Fe) of (68)Ga-SPIONs was subcutaneously injected in the hind paw of rats. The animals were imaged at 0-3 h and 25 h post injection with PET/CT, 9.4 T MR and CCDbased Cherenkov optical systems. A biodistribution study was performed by dissecting and measuring the radioactivity in lymph nodes, kidneys, spleen, liver and the injection site. The labeling yield was 97.3 ± 0.05% after 15 min and the (68)Ga-SPIONs were stable in human serum. PET, MR and Cherenkov luminescence imaging clearly visualized the SLN. Biodistribution confirmed a high uptake of the (68)Ga-SPIONs within the SLN. We conclude that generator produced (68)Ga can be labeled to SPIONs. Subcutaneously injected (68)Ga-SPIONs can enhance the identification of the SLNs by combining sensitive PET and high resolution MR imaging. Clinically, hybrid PET/MR cameras are already in use and (68)Ga-SPIONs have a great potential as a single-dose, tri-modality agent for diagnostic imaging and potential Cherenkov luminescent guided resection of SLN.

Entities:  

Keywords:  68Ga; Cherenkov imaging; PET/MR imaging; lymphatics; sentinel lymph node (SLN); superparamagnetic iron oxide nanoparticle (SPION)

Year:  2013        PMID: 24380046      PMCID: PMC3867730     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  31 in total

Review 1.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Sentinel node in breast cancer procedural guidelines.

Authors:  John Buscombe; Giovanni Paganelli; Zeynep E Burak; Wendy Waddington; Jean Maublant; Enrique Prats; Holger Palmedo; Orazio Schillaci; Lorenzo Maffioli; M Lassmann; Carlo Chiesa; Emilio Bombardieri; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12       Impact factor: 9.236

3.  Cerenkov imaging - a new modality for molecular imaging.

Authors:  Daniel Lj Thorek; Robbie Robertson; Wassifa A Bacchus; Jaeseung Hahn; Julie Rothberg; Bradley J Beattie; Jan Grimm
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

4.  A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer.

Authors:  G C Wishart; S-W Loh; L Jones; J R Benson
Journal:  Eur J Surg Oncol       Date:  2012-06-14       Impact factor: 4.424

5.  Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial.

Authors:  Francisco J Civantos; Robert P Zitsch; David E Schuller; Amit Agrawal; Russell B Smith; Richard Nason; Guy Petruzelli; Christine G Gourin; Richard J Wong; Robert L Ferris; Adel El Naggar; John A Ridge; Randal C Paniello; Kouros Owzar; Linda McCall; Douglas B Chepeha; Wendell G Yarbrough; Jeffrey N Myers
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

6.  Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma.

Authors:  Amanda Silverio; Matthew McRae; Stephan Ariyan; Deepak Narayan
Journal:  Ann Plast Surg       Date:  2010-10       Impact factor: 1.539

7.  99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.

Authors:  Renata Madru; Pontus Kjellman; Fredrik Olsson; Karin Wingårdh; Christian Ingvar; Freddy Ståhlberg; Johan Olsrud; Jimmy Lätt; Sarah Fredriksson; Linda Knutsson; Sven-Erik Strand
Journal:  J Nucl Med       Date:  2012-02-09       Impact factor: 10.057

8.  Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.

Authors:  E C Glass; R Essner; D L Morton
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

9.  68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors.

Authors:  Xiang Li; Samuel Samnick; Constantin Lapa; Ina Israel; Andreas K Buck; Michael C Kreissl; Wolfgang Bauer
Journal:  EJNMMI Res       Date:  2012-09-27       Impact factor: 3.138

10.  Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.

Authors:  Joost R van der Vorst; Boudewijn E Schaafsma; Floris P R Verbeek; Merlijn Hutteman; J Sven D Mieog; Clemens W G M Lowik; Gerrit-Jan Liefers; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer
Journal:  Ann Surg Oncol       Date:  2012-07-03       Impact factor: 5.344

View more
  20 in total

1.  Hybrid 99mTc-magnetite tracer for dual modality sentinel lymph node mapping.

Authors:  Aidan Cousins; Chris Tsopelas; George Balalis; Sarah K Thompson; Dylan Bartholomeusz; A Bruce Wedding; Benjamin Thierry
Journal:  J Mater Sci Mater Med       Date:  2018-05-29       Impact factor: 3.896

Review 2.  Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Authors:  James Rieffel; Upendra Chitgupi; Jonathan F Lovell
Journal:  Small       Date:  2015-07-16       Impact factor: 13.281

Review 3.  Utilizing the power of Cerenkov light with nanotechnology.

Authors:  Travis M Shaffer; Edwin C Pratt; Jan Grimm
Journal:  Nat Nanotechnol       Date:  2017-02-07       Impact factor: 39.213

Review 4.  Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.

Authors:  Rubel Chakravarty; Shreya Goel; Ashutosh Dash; Weibo Cai
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-01-26       Impact factor: 2.346

Review 5.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

Review 6.  Nanoparticles and radiotracers: advances toward radionanomedicine.

Authors:  Edwin C Pratt; Travis M Shaffer; Jan Grimm
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-23

Review 7.  Multimodality Imaging Agents with PET as the Fundamental Pillar.

Authors:  Dalong Ni; Emily B Ehlerding; Weibo Cai
Journal:  Angew Chem Int Ed Engl       Date:  2018-12-11       Impact factor: 15.336

Review 8.  Molecular Imaging in Nanotechnology and Theranostics.

Authors:  Chrysafis Andreou; Suchetan Pal; Lara Rotter; Jiang Yang; Moritz F Kircher
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488

Review 9.  Cerenkov luminescence imaging (CLI) for image-guided cancer surgery.

Authors:  M R Grootendorst; M Cariati; A Kothari; D S Tuch; A Purushotham
Journal:  Clin Transl Imaging       Date:  2016-05-24

Review 10.  Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma.

Authors:  Junjie Li; Fengyong Liu; Sanjay Gupta; Chun Li
Journal:  Theranostics       Date:  2016-06-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.